Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United States Antimony (UAMY) Common Equity (2016 - 2025)

United States Antimony's Common Equity history spans 15 years, with the latest figure at $71.8 million for Q3 2025.

  • For Q3 2025, Common Equity rose 185.55% year-over-year to $71.8 million; the TTM value through Sep 2025 reached $71.8 million, up 185.55%, while the annual FY2024 figure was $28.6 million, 12.07% up from the prior year.
  • Common Equity for Q3 2025 was $71.8 million at United States Antimony, up from $37.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $71.8 million in Q3 2025 and bottomed at $25.1 million in Q3 2024.
  • The 5-year median for Common Equity is $32.0 million (2021), against an average of $32.9 million.
  • The largest annual shift saw Common Equity surged 350.42% in 2021 before it dropped 19.92% in 2023.
  • A 5-year view of Common Equity shows it stood at $32.4 million in 2021, then fell by 1.54% to $31.9 million in 2022, then fell by 19.92% to $25.5 million in 2023, then rose by 12.07% to $28.6 million in 2024, then skyrocketed by 150.87% to $71.8 million in 2025.
  • Per Business Quant, the three most recent readings for UAMY's Common Equity are $71.8 million (Q3 2025), $37.5 million (Q2 2025), and $32.6 million (Q1 2025).